Making microbial genomics work for clinical and public health microbiology

Taj Azarian¹, Norelle L Sherry², Kate Baker³, Kathryn E Holt^{4

5}, Iruka N Okeke⁶

Affiliations

¹ Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, USA.
² Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
³ Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
⁴ Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
⁵ Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria 3004, Australia.
⁶ Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.

Editorial

Taj Azarian et al. Microb Genom. 2022 Sep.

. 2022 Sep;8(9):mgen000900.

doi: 10.1099/mgen.0.000900.

Taj Azarian¹, Norelle L Sherry², Kate Baker³, Kathryn E Holt^{4

5}, Iruka N Okeke⁶

¹ Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, USA.
² Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
³ Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
⁴ Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
⁵ Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria 3004, Australia.
⁶ Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.

No abstract available

Conflict of interest statement

The authors declare that there are no conflicts of interest.

1. Van Poelvoorde LAE, Bogaerts B, Fu Q, De Keersmaecker SCJ, Thomas I, et al. Whole-genome-based phylogenomic analysis of the belgian 2016–2017 influenza A (h3n2) outbreak season allows improved surveillance. Microb Genom. 2021;7:000643. doi: 10.1099/MGEN.0.000643/CITE/REFWORKS. - DOI - PMC - PubMed
1. Page AJ, Mather AE, Le-Viet T, Meader EJ, Alikhan N-F, et al. Large-scale sequencing of SARS-CoV-2 genomes from one region allows detailed epidemiology and enables local outbreak management. Microb Genom. 2021;7:000589. doi: 10.1099/mgen.0.000589. - DOI - PMC - PubMed
1. Chattaway MA, Gentle A, Nair S, Tingley L, Day M, et al. Phylogenomics and antimicrobial resistance of salmonella typhi and paratyphi A, B and C in england, 2016–2019. Microb Genom. 2021;7:000633. doi: 10.1099/MGEN.0.000633/CITE/REFWORKS. - DOI - PMC - PubMed
1. Pinto M, Borges V, Isidro J, Rodrigues JC, Vieira L, et al. Neisseria gonorrhoeae clustering to reveal major European whole-genome-sequencing-based genogroups in association with antimicrobial resistance. Microb Genom. 2021;7:1–18. doi: 10.1099/mgen.0.000481. - DOI - PMC - PubMed
1. Roberts LW, Forde BM, Hurst T, Ling W, Nimmo GR, et al. Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care. Microb Genom. 2021;7:000530. doi: 10.1099/mgen.0.000530. - DOI - PMC - PubMed